内啡素-1及其在癌症中的作用以及潜在的治疗机会
Madeline Harrison1, Dmitry Zinovkin2, Md Zahidul Islam Pranjol1
1Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QU, UK.
Biomedicines
|March 28, 2024
概括
内甲素-1 (ET-1) 是一种血管收缩剂,与癌症进展有关. 重用ET-1受体对抗剂显示出改善癌症治疗反应的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内甲素-1 (ET-1) 是一种强大的血管收缩剂,在各种疾病中起着重要作用.
- 在癌症中,ET-1信号经常过度激活,促进瘤的进展.
- ET-1有助于癌症的特征,如扩散,入侵,转移,血管生成和耐药性.
研究的目的:
- 审查ET-1促进癌症进展的机制.
- 确定针对癌症ET-1的治疗干预点.
- 探索用于ET-1向癌症治疗的药物重定向的潜力.
主要方法:
- 在癌症中对ET-1进行临床前和临床研究的文献综述.
- 对参与ET-1介导癌症进展的信号通路的分析.
- 检查ET-1受体抗剂及其治疗潜力.
主要成果:
- ET-1增强了包括扩散,入侵,转移和血管生成在内的关键癌症特征.
- ET-1涉及表皮-介质细胞转换 (EMT) 和对抗癌药物获得的耐药性.
- 临床前研究表明,向ET-1可以增强对其他癌症疗法的反应.
结论:
- ET-1是瘤学中一个重要的分子标.
- 重用现有的ET-1受体抗剂,已被批准用于肺高血压,是癌症治疗的一个有前途的策略.
- 目前正在进行的临床试验正在评估重定向ET-1受体对抗剂在各种癌症中的疗效.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
159
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
159
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


